Twin Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,655
Closed -$2.6M 316
2024
Q4
$2.6M Buy
3,655
+101
+3% +$71.9K 0.29% 94
2024
Q3
$3.74M Sell
3,554
-352
-9% -$370K 0.42% 59
2024
Q2
$4.11M Buy
3,906
+119
+3% +$125K 0.48% 47
2024
Q1
$3.64M Sell
3,787
-214
-5% -$206K 0.45% 59
2023
Q4
$3.51M Sell
4,001
-94
-2% -$82.6K 0.46% 59
2023
Q3
$3.37M Sell
4,095
-313
-7% -$258K 0.48% 51
2023
Q2
$3.17M Sell
4,408
-230
-5% -$165K 0.41% 64
2023
Q1
$3.81M Sell
4,638
-529
-10% -$435K 0.52% 48
2022
Q4
$3.73M Sell
5,167
-239
-4% -$172K 0.48% 57
2022
Q3
$3.72M Sell
5,406
-77
-1% -$53K 0.5% 50
2022
Q2
$3.24M Buy
5,483
+329
+6% +$194K 0.41% 70
2022
Q1
$3.6M Buy
5,154
+29
+0.6% +$20.3K 0.39% 77
2021
Q4
$3.24M Sell
5,125
-448
-8% -$283K 0.32% 104
2021
Q3
$3.37M Sell
5,573
-579
-9% -$350K 0.35% 91
2021
Q2
$3.44M Buy
6,152
+123
+2% +$68.7K 0.32% 105
2021
Q1
$2.85M Sell
6,029
-829
-12% -$392K 0.28% 114
2020
Q4
$3.31M Buy
6,858
+440
+7% +$213K 0.3% 104
2020
Q3
$3.59M Sell
6,418
-21
-0.3% -$11.8K 0.33% 95
2020
Q2
$4.02M Sell
6,439
-19
-0.3% -$11.9K 0.39% 79
2020
Q1
$3.15M Sell
6,458
-170
-3% -$83K 0.34% 91
2019
Q4
$2.49M Buy
6,628
+5,168
+354% +$1.94M 0.21% 148
2019
Q3
$405K Sell
1,460
-50
-3% -$13.9K 0.03% 258
2019
Q2
$473K Sell
1,510
-4,400
-74% -$1.38M 0.03% 260
2019
Q1
$2.43M Buy
+5,910
New +$2.43M 0.12% 205
2016
Q1
Sell
-400
Closed -$217K 285
2015
Q4
$217K Buy
+400
New +$217K 0.02% 266
2015
Q3
Sell
-400
Closed -$204K 274
2015
Q2
$204K Buy
+400
New +$204K 0.02% 251